Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.35 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | GPR3 | P46089 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10153690 | 0.79 | ALKBH5 (0.41) | ALKBH5FTOKDM4EATML3MBTL1 | |
| SCHEMBL10313361 | 0.71 | ALKBH5 (0.55) | ALKBH5FTOKDM4EATML3MBTL1 | |
| SCHEMBL10153697 | 0.70 | FGFR1 (0.37) | — | |
| SCHEMBL10153718 | 0.68 | ALKBH5 (0.39) | ALKBH5FTOKDM4EATML3MBTL1 | |
| SCHEMBL10153680 | 0.67 | EGFR (0.31) | — | |
| SCHEMBL10153480 | 0.67 | ALKBH5 (0.35) | ALKBH5FTOKDM4EATML3MBTL1 | |
| SCHEMBL10153516 | 0.66 | KDM4E (0.38) | ALKBH5FTOKDM4EATML3MBTL1 | |
| SCHEMBL10313371 | 0.66 | GPR3 (0.34) | ALKBH5FTOGPR3 | |
| SCHEMBL10153711 | 0.66 | ALKBH5 (0.41) | ALKBH5FTOKDM4EATML3MBTL1 | |
| SCHEMBL10313382 | 0.65 | SERPINE1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8421066-B2 | Organic electroluminescence device | UDC IRELAND LIMITED (IE) | 2013-04-16 | — | — | US | disclosed |
| US-8421066-B2 | Organic electroluminescence device | UDC IRELAND LIMITED (IE) | 2013-04-16 | — | — | US | disclosed |
| US-20120178928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2012-07-12 | — | — | US | disclosed |
| US-20120178928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2012-07-12 | — | — | US | disclosed |
| US-8174002-B2 | Organic electroluminescence device | FUJIFILM CORPORATION (JP) | 2012-05-08 | — | — | US | disclosed |
| US-8174002-B2 | Organic electroluminescence device | FUJIFILM CORPORATION (JP) | 2012-05-08 | — | — | US | disclosed |
| US-20100051928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2010-03-04 | — | — | US | disclosed |
| US-20100051928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2010-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100051928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | L1CAM, CHRM1, LEF1 | ALKBH5 1559/4885FTO 562/4885KDM4E 2229/4885 |
| US-20120178928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | L1CAM, CHRM1, LEF1 | ALKBH5 1559/4885FTO 562/4885KDM4E 2229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.